GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Other Long Term Assets

LakeShore Biopharma Co (LakeShore Biopharma Co) Other Long Term Assets : $4.21 Mil (As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Other Long Term Assets?

LakeShore Biopharma Co's other long-term assets for the quarter that ended in Sep. 2023 was $4.21 Mil.

LakeShore Biopharma Co's quarterly other long-term assets declined from Sep. 2022 ($3.58 Mil) to Mar. 2023 ($3.31 Mil) but then increased from Mar. 2023 ($3.31 Mil) to Sep. 2023 ($4.21 Mil).

LakeShore Biopharma Co's annual other long-term assets declined from Mar. 2021 ($14.86 Mil) to Mar. 2022 ($4.93 Mil) and declined from Mar. 2022 ($4.93 Mil) to Mar. 2023 ($3.31 Mil).


LakeShore Biopharma Co Other Long Term Assets Historical Data

The historical data trend for LakeShore Biopharma Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Other Long Term Assets Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23
Other Long Term Assets
14.86 4.93 3.31

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Other Long Term Assets Get a 7-Day Free Trial - 4.93 3.58 3.31 4.21

LakeShore Biopharma Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Traded in Other Exchanges
Address
38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.